Stroke care in Iran: Although there has been a significant improvement in stroke care in Iran, reports indicate that the utilization of intravenous tissue plasminogen activator (IV-tPA) in Iran is lower than many other countries.   16  At the same time, there is no fine-tuned national standard for developing stroke centers in Iran. The gene discussed is PLAT; the disease is stroke disorder.